
Dapagliflozin cuts cardiovascular events in patients with heart failure, T2D
For patients with heart failure and type 2 diabetes (T2D), dapagliflozin does not reduce urinary albumin-to-creatinine ratio (UACR) but does reduce some cardiovascular events, according to a study published online Nov. 27 ...
Dec 30, 2023
0
2